Dr. Samuel Kikandi, PhD
Deputy Director – Principal Engineer
Dr. Samuel Kikandi holds a PhD in Chemistry from the State University of New York at Binghamton, NY, specializing in electrochemistry and degradation of endocrine disrupting chemicals (EDCs). Upon entering the pharmaceutical industry, he identified the critical link between EDCs and extractables/leachables (E/L) in single-use systems. With 15 years of pharmaceutical experience, Dr. Kikandi serves as Deputy Director-Principal Engineer at Sanofi Inc., leading Material Science and E/L programs. His expertise is widely sought across Sanofi’s global business units and by external organizations for consultation on complex E&L challenges. Dr. Kikandi enjoys active contributions to industry advancement through ELSIE and BioPhorum expert teams, addressing critical topics including USP665, USP661.1, 661.2 standards and more.
DAY 2: March 6th, 2026
SESSION: Swift Extractables and Leachables Qualification of Pharmaceutical Product
Contact Single Use Systems
◆
